Frequency and clinical significance of ischemic preconditioning during percutaneous coronary intervention

Journal of the American College of Cardiology

Volumn 42, Issue 6, 2003, Pages 998-1003

  Laskey, Warren K ^a,b   Beach, Dana ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; LACTIC ACID;

ADULT; AGED; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; FEMALE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INJURY; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0041386033     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00909-4     Document Type: Article

References (30)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
2. 1-adenosine receptors in the rabbit heart. Circulation 1991;84:350-6.
3. Li Y, Kloner RA. The cardioprotective effects of ischemic "preconditioning" are not mediated by adenosine receptors in rat hearts. Circulation 1993;87:1642-8.
4. Schott RJ, Rohmann S, Braun E, et al. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990;66:1133-44.
5. Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol 1987;253:H1470-6.
6. Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 1991;84:341-9.
7. Kloner RA, Shook T, Przyklenk K, et al. Previous angina alters in-hospital outcome in TIMI-4: a clinical correlate to preconditioning? Circulation 1995;91:37-45.
8. Muller DWM, Topol EJ, Califf RM, et al., and TAMI Study Group. Relationship between antecedent angina pectoris and short term prognosis after thrombolytic therapy for acute myocardial infarction. Am Heart J 1990;119:224-31.
9. Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation 1995;91:291-7.
10. Deutsch E, Berger M, Kussmaul WG, et al. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Circulation 1990;82:2044-51.
11. Tomai F, Crea F, Gaspardone A, et al. Mechanisms of cardiac pain during coronary angioplasty. J Am Coll Cardiol 1993;22:1992-6.
12. Cribier A, Korsatz L, Koning R, et al. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. J Am Coll Cardiol 1992;20:578-86.
13. Leesar MA, Stoddard M, Ahmed M, et al. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation 1997;95:2500-7.
14. Strauer BE, Heidland UE, Heintzen MP, et al. Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance. J Am Coll Cardiol 1996;28:1119-26.
15. Lee T-M, Su S-F, Chou T-F, et al. Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation 2002;105:334-40.
16. Lim R, Laskey WK. Ischemic preconditioning in unstable coronary syndromes: evidence for time dependence. J Am Coll Cardiol 1997;30:1461-5.
17. Vaitkus PT, Miller JM, Buxton AE, et al. Ischemia-induced changes in human endocardial electrograms during percutaneous transluminal coronary angioplasty. Am Heart J 1994;127:1481-90.
18. Leesar MA, Stoddard MF, Manchikalapudi S, Bolli R. Bradykinin-induced preconditioning in patients undergoing coronary angioplasty. J Am Coll Cardiol 1999;34:639-50.
19. + channel blocker. Circulation 1997;95:2500-7.
20. ATP channel. Annu Rev Physiol 2000;62:79-109.
21. ATP channels. Physiol Rev 1998;78:227-45.
22. Liu Y, Sato T, O'Rourke B, et al. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 1998;97:2463-9.
23. Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications. Part 2. Circulation 2001;104:3158-67.
24. Matsuyama N, Leavens JE, Gaudette GR, et al. Ischemic but not pharmacological preconditioning requires protein synthesis. Circulation 2000;102 Suppl III:III312-8.
25. Kloner RA, Yellon D. Does ischemic preconditioning occur in patients? J Am Coll Cardiol 1994;24:1133-42.
26. Laskey WK. Beneficial impact of preconditioning during PTCA on creatine kinase release. Circulation 1999;99:2085-9.
27. Yellon DM, Alkhulaiff AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-7.
28. Jennings RB, Sebbag L, Schwartz LM, et al. Metabolism of preconditioned myocardium: effect of loss and reinstatement of cardioprotection. J Mol Cell Cardiol 2001;33:1571-88.
29. Bolli R. The late phase of preconditioning. Circ Res 2000;87:972-83.
30. Leesar MA, Stoddard MF, Dawn B, et al. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 2001;103:2935-41.